GBS
Woodstock, GA, United States
Woodstock, GA, United States

Time filter

Source Type

CHICAGO--(BUSINESS WIRE)--USG Corporation (NYSE: USG) (“USG”) today announced the early results of the previously announced cash tender offer (the “Tender Offer”) for any and all of its outstanding 7.75% Senior Notes due 2018 (the “Notes”). The Tender Offer is being made on the terms and subject to the conditions set forth in the Offer to Purchase dated May 1, 2017 (the “Offer to Purchase”) and the related Letter of Transmittal (the “Letter of Transmittal”). The Tender Offer is scheduled to expire at 11:59 p.m., New York City time, on May 26, 2017, unless extended or earlier terminated as described in the Offer to Purchase (such time and date, as the same may be extended, the “Expiration Time”). As of 5:00 p.m., New York City time, on May 12, 2017 (the “Early Tender Time”), according to Global Bondholder Services Corporation (“GBS”), the Depositary and Information Agent in connection with the Tender Offer, tenders were received from holders of Notes and not validly withdrawn as outlined in the following table: Subject to the terms and conditions of the Tender Offer, holders of Notes who validly tendered and did not withdraw their Notes at or prior to the Early Tender Time will be entitled to receive $1,044.30 per $1,000 principal amount of Notes tendered, which includes the early tender premium of $30.00 per $1,000 principal amount of Notes tendered (the “Early Tender Premium”). Holders of Notes who validly tender their Notes after the Early Tender Time but at or prior to the Expiration Time will be entitled to receive $1,014.30 per $1,000 principal amount of Notes tendered, subject to the terms and conditions of the Tender Offer, and will not be entitled to receive the Early Tender Premium. In addition, holders whose Notes are accepted for purchase in the Tender Offer will be entitled to receive accrued interest up to, but not including, the applicable settlement date of the Notes, payable in cash. Payment for Notes tendered at or prior to the Early Tender Time is expected to be May 15, 2017 (such acceptance and payment, an “Early Settlement”). Payment for Notes validly tendered after the Early Tender Time but at or prior to the Expiration Time and accepted for purchase will be made promptly after the Expiration Time. Withdrawal rights with respect to the Notes tendered expired at 5:00 p.m., New York City time, on May 12, 2017, and holders who validly tender Notes after the Early Tender Time do not have withdrawal rights. The Tender Offer is subject to the satisfaction or waiver of a number of conditions as set forth in the Offer to Purchase, including the receipt by USG of proceeds from a proposed debt financing on terms reasonably satisfactory to USG, in its sole discretion, generating net proceeds in an amount that USG deems sufficient, together with cash on hand, to effect the repurchase of the Notes validly tendered and accepted for purchase pursuant to the Tender Offer, including payment of any premiums, Accrued Interest (as defined in the Offer to Purchase) and costs and expenses incurred in connection therewith. If USG proceeds with an Early Settlement, all conditions to the Tender Offer will be deemed to be waived, and USG will thereafter accept for purchase and pay for any Notes validly tendered in the Tender Offer To the extent that any Notes are not validly tendered in the Tender Offer, USG intends to redeem such remaining Notes pursuant to the redemption provisions of the indenture governing the Notes at the “make-whole” redemption price specified for the Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. USG intends to deliver an irrevocable notice of redemption to the trustee at the completion of the debt financing. However, no assurance can be given that such untendered Notes will be redeemed as contemplated or at all. USG has retained Wells Fargo Securities, LLC to serve as dealer manager for the Tender Offer. USG has appointed GBS to serve as the depositary and information agent for the Tender Offer. For additional information regarding the terms of the Tender Offer, please contact Wells Fargo Securities, LLC at (866) 309-6316 (toll free) or (704) 410-4760 (collect). Requests for documents and questions regarding the Tender Offer should be directed to GBS at (212) 430-3774 (banks and brokers) or (866) 470-4200 (all others). None of USG, its board of directors, the dealer manager, GBS or the trustee for the Notes, or any of their respective affiliates, is making any recommendation as to whether Holders should tender any Notes in response to the Tender Offer. Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of Notes to tender. Documents for the Tender Offer, including the Offer to Purchase and the related Letter of Transmittal, are available at www.gbsc-usa.com/USG/, and may also be obtained by contacting GBS by telephone. This announcement is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell securities. The Tender Offer is being made solely by means of the Offer to Purchase and the related Letter of Transmittal. The Tender Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In those jurisdictions where the securities, blue sky or other laws require any tender offer to be made by a licensed broker or dealer, the Tender Offer will be deemed to be made on behalf of USG by the dealer manager or one or more registered brokers or dealers licensed under the laws of such jurisdiction. USG Corporation is an industry-leading manufacturer of building products and innovative solutions. Headquartered in Chicago, USG serves construction markets around the world through its United States Gypsum Company and USG Interiors, LLC subsidiaries and its international subsidiaries, including its USG Boral Building Products joint venture. Its wall, ceiling, flooring, sheathing and roofing products provide the solutions that enable customers to build the outstanding spaces where people live, work and play. Its USG Boral Building Products joint venture is a leading plasterboard and ceilings producer across Asia, Australasia and the Middle East. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 related to management’s expectations about future conditions, including but not limited to, the terms and timing of the Tender Offer and the redemption of any remaining Notes. Actual business, market or other conditions may differ materially from management’s expectations and, accordingly, may affect USG’s sales and profitability or other results and liquidity. Any forward-looking statements represent USG’s views only as of today and should not be relied upon as representing USG’s views as of any subsequent date and USG undertakes no obligation to update any forward-looking statement. Actual results may differ materially due to various other factors, including: economic conditions, such as employment, household formation, home ownership rate, existing home price trends, availability of mortgage financing, interest rates, consumer confidence, job growth and discretionary business investment; USG’s ability to maintain or achieve price increases; the loss of one or more major customers; the impact on USG’s performance and financial results due to the disposition of L&W Supply, one of USG’s largest customers; competitive conditions, such as price, quality and range of products; unexpected operational difficulties or catastrophic events at USG’s facilities; an increasing number of USG’s customers having significant buying power; increased costs, or decreased availability, of key raw materials or energy; USG’s ability to successfully operate the joint venture with Boral Limited, including risks that USG’s joint venture partner, Boral Limited, may not fulfill its obligations as an investor or may take actions that are inconsistent with USG’s objectives; exposure to risks of operating internationally; USG’s ability to innovate and protect USG’s intellectual property and other proprietary rights; USG’s ability to make capital expenditures and achieve the expected return on investment; a disruption in USG’s information technology systems; significant changes in factors and assumptions used to measure USG’s defined benefit plan obligations; changes in laws or regulations, including environmental and safety regulations; the outcome in legal and governmental proceedings; the ability of a small number of stockholders to influence USG’s business and stock price; USG’s ability to successfully pursue and complete acquisitions, joint ventures and other transactions to complement or expand USG’s businesses; USG’s ability to return capital to stockholders; the occurrence of an “ownership change” within the meaning of the Internal Revenue Code; ability to incur substantial additional indebtedness; the effects of acts of terrorism or war upon domestic and international economies and financial markets; and acts of God. USG assumes no obligation to update any forward-looking information contained in this press release. Additional information concerning these and other factors may be found in USG’s filings with the Securities and Exchange Commission, including the “Risk Factors” in USG’s most recent Annual Report on Form 10-K.


News Article | May 9, 2017
Site: www.prweb.com

JPD Financial is sponsoring the 17th Shared Services for Finance & Accounting. JPD Financial will be joined by top industry leaders, June 21-23 at the Highlands in Dallas, Texas. In its 17th installment, Shared Services for F&A offers greater interactivity and has an 80% new speaker faculty. The 2017 program will be premiering a series of hour-long clinics to help attendees optimize their 3rd-party provider relationships, master data management, and integrate Smart Technology into their automation roadmaps. Speakers include Jonathan Kepets, Global Head of Business Analysis & Reporting, Cantor Fitzgerald; Bryan Ternes, Vice President of Finance – GBS, Levi Strauss & Co.; Brenda McCoy, Americas R2R, Global Finance Shared Services, Apple, Inc.; John Nderitu, Staff VP, Business Improvement Group, Anthem; Scott Gillan, Executive Director of Transformation & Service Management, Enterprise Financial Services, Warner Bros.; and Misty Thorpe, Business Leader, GBSC Accounting Services, and MasterCard. “With an impressive line-up of speakers and hands-on clinics, this year’s event Shared Services for F & A promises attendees exceptional opportunities to learn and network with experts,” said Alexa Bradley, Vice President of Business Development and Marketing for JPD Financial. “We look forward to contributing to the program and helping attendees learn how to transform their service delivery into the indispensable backbone of the business.” The event is designed to include a four pre-conference workshops, 2 main conference days, Process Improvement Clinics, Quickfire Intelligence Labs, and more than 7 hours of networking to discuss the most important challenges and most effective strategies and solutions within the industry. JPD Financial will be featured in the comprehensive expo hall that is showcasing innovative solutions and services for the industry. JPD is a professional service provider that employs a team of highly skilled individuals who communicate directly with their client’s suppliers. As the audit landscape continues to evolve, JPD has become proficient in rebalancing expectations and offering a solution that is advantageous to its clients. About JPD Financial: For more than 30 years, JPD Financial has worked behind the scenes on behalf of Fortune 1000 clients to research and uncover funds that would otherwise be lost in today’s automated systems and written off due to accounting miscommunications. They work with their clients’ suppliers to research credits, overpayments, and misapplied or duplicate payments that appear on their records, but which may not appear on the standard statements their clients receive. JPD Financial is headquartered in Santa Clara, California with a European office in Harpenden, UK to serve its global clients. JPD Financial’s client base includes major vertical industries such as healthcare, telecommunications, energy, consumer goods, oil and gas, and manufacturing. For more information, visit http://www.JPDFinancial.com. About IQPC: IQPC produces 1,500 global events that are custom-tailored to the unique needs of business executives. Founded in 1973, IQPC leverages an office network that spans six continents and a wealth of intellectual capital to provide an unparalleled portfolio of conferences and seminars. For more information, please visit http://www.iqpc.com.


News Article | April 26, 2017
Site: www.prnewswire.com

Die Bewerber diese Jahr kämpfen um die begehrte Auszeichnung in einer von fünf Kategorien: Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation und - die 2017 erstmals aufgeführte Kategorie - Excellence in Automation (unterstützt von Automation Anywhere). In diesen stark umkämpften Kategorien haben es Unternehmen wie Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC und Shell in zwei Kategorien in die Shortlist geschafft. Zu weiteren nominierten Unternehmen gehören UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M und Lufthansa. Account NI, das Sieger-Unternehmen aus dem Vorjahr, wurde in der Kategorie Excellence in Transformation erneut in die Shortlist aufgenommen und hätte somit die Möglichkeit, den Award zum zweiten Mal in Folge zu gewinnen. Das Unternehmen muss sich mit Auftritten von Coca-Cola Hellenic, Hexaware, Shell and Sonae messen. Die Verleihung 2017 wird von Experten aus dem Bereich Shared Services beurteilt: Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops und Paul Theaker. Die Excellence Awards Ceremony wird anlässlich der alljährlichen Shared Services and Outsourcing Week - diese geht in die 17. Runde - abgehalten und zwar vom 15.-18. Mai 2017 - die Gewinner werden zu diesem Zeitpunkt bekanntgegeben. SSOW ist der erste europäische Shared Services-Event mit 580+ führenden Unternehmen aus den Bereichen Shared Services, GBS, Outsourcing and Transformation.


News Article | April 26, 2017
Site: www.prnewswire.com

The applicants this year are competing to win a coveted award in one of the 5 categories; Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation, and the new for 2017 category, Excellence in Automation, sponsored by Automation Anywhere.  Across these highly competitive categories, Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC and Shell have all made the shortlist in 2 categories, whilst other nominees include; UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M and Lufthansa. After winning in 2016, Account NI have found themselves on the shortlist for the Excellence in Transformation category once again, and could to win the award for a second year in a row. They are up against entries from Coca-Cola Hellenic, Hexaware, Shell and Sonae. The 2017 Awards are judged by experts in the Shared Services industry; Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops and Paul Theaker. The Excellence Awards Ceremony is hosted during the 17th Annual Shared Services & Outsourcing Week taking place on the 15th - 18th May 2017 where the winners will be announced. SSOW is the premier European Shared Services Event which hosts 580+ Shared Services, GBS, Outsourcing and Transformation leaders. For more information go to http://awards.ssoweek.com


News Article | April 26, 2017
Site: www.prnewswire.co.uk

The applicants this year are competing to win a coveted award in one of the 5 categories; Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation, and the new for 2017 category, Excellence in Automation, sponsored by Automation Anywhere.  Across these highly competitive categories, Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC and Shell have all made the shortlist in 2 categories, whilst other nominees include; UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M and Lufthansa. After winning in 2016, Account NI have found themselves on the shortlist for the Excellence in Transformation category once again, and could to win the award for a second year in a row. They are up against entries from Coca-Cola Hellenic, Hexaware, Shell and Sonae. The 2017 Awards are judged by experts in the Shared Services industry; Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops and Paul Theaker. The Excellence Awards Ceremony is hosted during the 17th Annual Shared Services & Outsourcing Week taking place on the 15th - 18th May 2017 where the winners will be announced. SSOW is the premier European Shared Services Event which hosts 580+ Shared Services, GBS, Outsourcing and Transformation leaders. For more information go to http://awards.ssoweek.com


News Article | April 21, 2017
Site: co.newswire.com

It's the idea of incremental growth—and just never giving up, being resilient, and always moving forward The morning of September 17, 2004, started like many other days for businessman and entrepreneur Barry Shore. At 55, Barry had just returned from a trip overseas with his 17-year old son. Barry is the Founder and CEO of Dlyte.com and is a successful serial entrepreneur across a variety of industries. Despite waking up physically strong, by the end of the day, Barry would be a quadriplegic, unable to move anything except his head—left to right. “I was standing up in the morning, and in the evening, I was in the hospital paralyzed from my neck down,” says Barry. Barry was later diagnosed with Guillain-Barré syndrome (GBS), a rare disorder in which the body's immune system attacks the nervous system. The disorder can be so devastating because it strikes without warning—and because there is no specific, singular cause known by doctors at this time. GBS affects about one person in 100,000, according to the National Institute of Neurological Disorders and Stroke. Barry would remain in various hospitals for 4 and a half months. He had a hospital bed in his own home for 2 years. He couldn’t turn over by himself, and he had braces on both legs—from his hips down to his ankles—for more than a year. But if you saw or heard Barry speak today, you’d be able to tell he’s full of life and just as vibrant and driven as before being diagnosed with GBS. Barry credits prayer, therapy, and love—PTL as he calls it—and conscious leadership as the factors that have turned his setback into a positive outcome.


News Article | April 25, 2017
Site: www.sciencemag.org

Leah Durant was cleaning the unfinished basement of her home in Falls Church, Virginia, one day in October 2010 when she scraped her hand on a rusty nail. Not long after, the then-37-year-old lawyer was seated in her doctor's office, preparing to receive a tetanus vaccine—a preventive measure that since 1947 has reduced U.S. fatalities caused by the soil-borne bacterium Clostridium tetani 500-fold. Her physician stood to her left and leaned over her shoulder with the needle. The pain was immediate, and so excruciating that Durant screamed. "I knew right then and there that something had gone terribly wrong," she recalls. Six years later, driven by that painful jab, Durant has become a vaccine injury lawyer with a bustling practice in Washington, D.C., half a mile from a red brick building that houses what is popularly known as the vaccine court. Thirty years ago, federal law established that court—part of the U.S. Court of Federal Claims—to remove vaccine injury cases from the civil courts, where a wave of lawsuits had spooked vaccinemakers and was threatening to cause vaccine shortages. That law, the National Childhood Vaccine Injury Act of 1986, limited the legal liability of vaccinemakers and created the National Vaccine Injury Compensation Program (VICP) in the Department of Health and Human Services. The VICP is a no-fault route for people injured by vaccines to win damages from a government trust fund financed by an excise tax on vaccines. (Despite the law's title, adults, too, can win compensation for vaccine injuries.) Since its first case in 1988, the vaccine court has adjudicated more than 16,000 petitions and dismissed two-thirds of them. To the successful petitioners, and their lawyers, it has awarded about $3.6 billion. The system has attracted scores of attorneys, who are paid hourly legal fees of up to $430 regardless of whether a claim succeeds. The court's website lists 195 lawyers nationwide who are willing to take vaccine cases, although petitioners can hire others. Many are clearly in search of their piece of the $3.7 billion sitting in the trust fund today. A sampling of the bold proclamations on vaccine lawyers' websites include these: "WE HAVE RECOVERED MILLIONS FOR OUR CLIENTS"; "Pursue Compensation"; and "NO COST to you." Durant's website makes the same point, although in smaller fonts and classier prose. Yet she might be unique in that her own experience drove her into vaccine law. Once an immigration lawyer at the U.S. Department of Justice and later the outspoken director of a nonprofit advocating for stricter enforcement of immigration law, she changed her career course and ultimately became a full-time vaccine injury lawyer after that tetanus shot gone wrong. Durant's injury, her legal practice, and the petitions filed at the vaccine court offer a window into the real risks of vaccination. Those risks can be as severe as extremely rare, dramatic deaths from anaphylaxis—an overwhelming allergic reaction—or as quotidian as shoulder injuries like Durant's. And although petitions to the court do include the kind of bogus injuries that frighten parents, the most common, and prominent, of those has not been warmly received: Not once has the court compensated a petitioner claiming that a vaccine caused autism. Durant, who says she makes her living by winning compensation for genuine vaccine injuries, emphasizes the point. "Vaccines keep us healthy. They eradicate disease. If I had children, I would get them vaccinated." The vaccine court's data show that bona fide vaccine injuries are rare. For every million vaccine doses eligible for compensation that were distributed in the decade beginning in 2006, the court compensated one injury victim. Depending on the gravity of the disease in question, receiving a vaccine is orders of magnitude less dangerous than staying unvaccinated. The tetanus vaccine that Durant received causes a life-threatening allergic reaction in at most 0.0006% of people who get the shot. The U.S. case fatality rate from tetanus, by contrast, is 13.2%. "One injury from vaccines is one too many, but it is also important to keep perspective," says Sarah Atanasoff, a physician at the VICP in Rockville, Maryland. "The benefits of vaccination to the individual, the local community, and the nation as a whole far outweigh the risks." Petitions filed with the court suggest that among those real risks, shoulder injuries have become by far the most common. Rarer injuries include Guillain-Barré syndrome (GBS), a neurological malady associated with some influenza vaccines; anaphylaxis, a life-threatening allergic reaction that almost any vaccine can cause and occurs 1.3 times per million vaccinations; intussusception, an intestinal blockage that occurs in between one and five of every 100,000 infants vaccinated against rotavirus; and brachial neuritis (also called Parsonage-Turner syndrome), a painful inflammation of the nerves supplying the hand and arm, which afflicts up to 10 of every million tetanus vaccinees. Vaccination also can provoke (as well as prevent) febrile seizures, which occur in up to 5% of toddlers who become feverish for any reason. Those seizures are most common after measles, mumps, and rubella (MMR) or the combined MMR and chickenpox vaccine, occurring in up to 300 of each million children vaccinated. Typically lasting 1 to 2 minutes, the seizures can be frightening to witness. But they are transient and almost always without lasting effects. A cadre of medical experts at the VICP initially assesses injury claims, calling in lawyers from the Department of Justice to defend the government if they think the facts don't support a vaccine injury claim. Eight senior attorneys—called special masters and appointed by judges on the U.S. Court of Federal Claims—rule on the claims. The court is rarely asked to determine whether an injury has occurred—that is virtually always abundantly clear—but whether a vaccine caused that injury. Where the evidence shows that a vaccine did serious or fatal damage, as with a 4-year-old girl who died of anaphylaxis the day after receiving several childhood vaccines, the court awards substantial damages. Her parents received the maximum death benefit under the law: $250,000. But the court also draws lines when petitioners and their lawyers present weak, implausible cases—like that of a 4-month-old boy who was vaccinated and that night died, facedown, while sleeping under the same heavy covers as his mother. An autopsy found clear evidence that the baby had suffocated—and no evidence of vaccine-induced injury. The case was dismissed. And in 2010, the court declined to award compensation in an omnibus proceeding that grouped more than 5000 autism claims. Such petitions continue to fail. One typical, recent opinion reads: "The factual record simply does not support Petitioners' contention that the MMR vaccine had any connection to R.A.'s ASD [autism spectrum disorder] diagnosis." The stabbing pain in Durant's left shoulder worsened in the days after her tetanus shot. "I felt like my arm was falling off," she recalls. She couldn't carry her purse or hold a cup of coffee. She couldn't lift that arm above her head or place it on the steering wheel of her car. She contacted her doctor and relayed her fears that, whatever was going on, the vaccine had caused it. "That's not possible," she recalls him saying. "Needles aren't long enough to do that kind of damage." In fact, needles can do precisely that kind of damage if a vaccine is improperly administered too high on the upper arm, and the needle pierces the deltoid muscle and continues into the shoulder joint. There, physical damage from the needle and, more important, an immune reaction to the injected vaccine can provoke an inflammation that damages tendons, ligaments, and the fluid-filled sacs called bursas that reduce friction in the joint. Late in 2010, scientists in the government's VICP published a description of such injuries and gave them a name: shoulder injury related to vaccine administration. The government physicians, led by Atanasoff, had identified 13 adults who between 2006 and 2010 petitioned the court for compensation for shoulder injuries and submitted voluminous medical records. None had previous shoulder problems, but each had developed sudden, acute pain and a limited range of motion in a shoulder after a vaccination. Four patients needed surgery, and half of those needed a second operation. Their MRI reports showed shoulder joints riddled with inflammation. Half reported that the vaccine had been given "too high" in the shoulder. Most had received the vaccine in question—flu or tetanus, and in one case human papillomavirus—in the past, suggesting that the body's immune system was already primed to attack, in an immune response that led to serious, prolonged inflammation in the joint. The clinical results are not surprising to G. Russell Huffman, an orthopedic surgeon who specializes in shoulders at the University of Pennsylvania Perelman School of Medicine. "If you create this inflammatory response in the shoulder joint, it's going to be manifested not with an hour of pain but with days, months, or possibly years of pain." Shoulder injury petitions to the VICP have surged as annual flu vaccination has become routine—in 2010, the Centers for Disease Control and Prevention recommended it for everyone except the youngest babies. In 2012, the vaccine court published 15 decisions in which people alleged shoulder injuries. By 2016, 492 of its published decisions mentioned "shoulder injury." That trend may accelerate: Last month, the government added shoulder injuries to a list of injuries for which a victim does not have to prove causation. Now , petitioners need only document that they received a vaccine and within 48 hours developed acute, movement-limiting pain in that previously healthy shoulder. Durant went through 6 months of physical therapy followed by 18 months of at-home exercises before she felt fully recovered, she says. By then, she had begun to study vaccine injuries and case law. Gradually, she began to take on clients and build a full-time practice. If not for her injury, "I certainly wouldn't be doing this today," she says. Durant estimates that about 70% of her scores of clients past and present sustained shoulder injuries; the other 30% say they suffered from rare disorders such as brachial neuritis or GBS. Both diseases are thought to result from an autoimmune attack on the myelin that speeds conduction along the peripheral nerves. Both can therefore be triggered by a ramping up of the immune response—typically after an infection but also, on occasion, after a vaccine. Both can be seriously disabling. GBS can paralyze the legs, arms, and even the respiratory muscles. Brachial neuritis can leave arm and hand muscles weakened and wasted. That was the case for Mark Davis, an implant dentist in Clearwater, Florida. At age 70, he had no plans to retire. But one fall afternoon in 2013, his right hand began cramping so badly that he had to remove the dental tool he was holding by prying open his fingers with his left hand. Over the ensuing weeks, part of his hand grew numb and he lost the ability to retract his thumb—a crucial movement for operating syringes. He awoke one night with excruciating pain extending from his right shoulder to his hand. Remembering his anatomy from dental school, he mused that his pain and the growing weakness in his arm and hand tracked with the brachial plexus, a network of nerves that supplies the limb . Soon, he was forced to sell his practice at a loss. Weeks later, Davis happened to glance at a medical bill showing a routine tetanus injection he had received 2 weeks before his symptoms began. When he Googled "brachial plexus" and "tetanus vaccine," "my computer lights up like I've gone to the circus," he recalls. Davis had developed what Joseph Feinberg, a rehabilitation medicine specialist at the Hospital for Special Surgery in New York City, diagnosed several months later as brachial neuritis. Not long after that, again using the internet, Davis found Durant. The vaccine court is still processing his petition: The government contends that irritated nerves in his cervical spine—a problem common in dentists who spend a lifetime leaning over patients—may be responsible. Today, at 75, Davis's right bicep is withered. "My greatest loss is my inability to do what I really loved to do the most: work," he says. Still, he would get the tetanus shot again. "I am a very strong supporter of vaccination." Durant is still considering whether to petition the court for compensation for her own injury. "I am keeping my options open." On one thing she is not undecided: the importance of educating about vaccines. When parents contact her, asking how to get around a vaccination requirement for school entry, she doesn't offer help. Instead, she says, "I talk to them about my personal view about vaccinations and the fact that I feel vaccines are safe."


News Article | March 14, 2017
Site: www.techtimes.com

Life is unexpected and miracles occur when one least expects it. Captain Brandon Caldwell and his family's story is one which reinstates belief. Captain Caldwell, who came back after two months of deployment in Antarctica, never expected such a warm welcome — especially from his nine-month old boy Reagan who is visually impaired. Regan received his pair of blue glasses right after his dad was deployed to Antarctica, welcomed his military father with a smile of joy. The emotional moment was captured by his wife Amanda, who shared the video on her Facebook page. The video shows Regan sitting on his father's lap, who was still in his army uniform, singing "Patty Cake" to his son. With the new pair of blue glasses, Reagan watches his dad and listens to every word he utters. As the song continues, the boy is seen resting his head on his father's chest. Being so many months away from his nine-month old son, Caldwell thought Reagan may have forgotten him, which was certainly not the scene. "You can see how hard it was for Brandon to be away from Reagan by the emotion he showed when he finally had him in his arms again," shared Amanda to Cater News. Amanda who was a school teacher by profession, like most expectant mothers underwent testing and found she was positive with Group B Strep (GBS) in the 35 to 37 weeks. According to the American Pregnancy Association, one out of every pregnant woman is tested positive with GBS, so this was nothing to be worried about. However, after being tested with GBS, she was not informed anything about the severe consequences her child was going to suffer. The initial stage with baby Reagan was not an easy one for Amanda, as the child was detected with meningitis and sepsis 20 days after his birth. As a result of which, his family members took him to the Intensive Care Unit (ICU). The child also had to go through several seizures as a result of suffering from meningitis and sepsis. Based on his MRI results, the doctors suspected that the little baby may suffer from cerebral palsy or could be even mentally handicapped. However, Reagan is now showing positive improvements, and is also taking classes for speech therapy, visual impairment, as well as special education at home. His mother, Amanda left her job as a teacher to be with Reagan and also takes him to the doctor regularly, which also includes visits to the hospitals every six weeks. One can be a part of Reagan's journey by visiting Amanda's Facebook page, where she shares his updates, details about GBS, as well the medical challenges faced by the family. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.


Itransition Included on the 2017 Global Outsourcing 100 List with Maximum Scores in Three Areas Itransition is included in the Global Outsourcing 100 List for 9 successive years; achieves special recognition in 5 areas and maximum scores in 3 areas. The 2017 Global Outsourcing 100 recognizes the world’s best outsourcing service providers. These list is based on applications received, and judging is based on a rigorous scoring methodology that includes reviews by an independent panel of IAOP customer members with extensive experience in selecting outsourcing service providers and advisors for their organizations. The 2017 panel is led by IAOP CEO Debi Hamill and Chairman Michael F. Corbett. The panel includes: · Daniel Beimborn, Professor, Frankfurt School of Finance & Management · Teresa Harris, COP, Global Supplier Relationship Manager, GE · Mary D. Lewis, Sourcing Manager II, Supply Chain Management, Sprint · Cheryl Seely, COP, Manager, Thomson Reuters · Paul Quaglia, COP, CIO, Scientific Games · Scott Singer, Managing Director, GBS, Rio Tinto As before, Size and Growth, Awards and Certifications, Programs for Innovation and Corporate Social Responsibility, as well as Customer References were the scored areas influencing the overall company score awarded by IAOP. To achieve “stars” in these categories, a company had to score 5 or more points (on a scale of 0-8). According to the 2017 GO100 results, Itransition not only scored above the industry average, but also beat its own overall score from 2016. Itransition stood out from competitors by being named Top Company in the areas of Customer References, Awards & Certifications, and Programs for Innovation, for which it received 8 points, the absolute maximum number. In the Programs for Innovation area, Itransition reached 8 as well beating its 2016 score by 3 points. The company also upped its 2016 score in the Company Awards area by 4 points. Having been included on the GO100 list for the last 9 consecutive years, Itransition received an additional distinction of Super Star of the Global Outsourcing 100 for demonstrating sustained excellence. “Buyers understand there are hundreds of qualified service providers and advisors out there, but what they really need to understand now is what makes each one exceptional,” said IAOP CEO, Debi Hamill. “The Global Outsourcing 100 and World’s Best Advisors lists have done just that. We are proud to recognize Itransition for being among the highest rated companies in Customer References, Company Awards, Company Certification, and Programs for Innovation.” “Since 2011, Itransition has enabled my organization to deliver quality products against tight deadlines. In late 2015, my organization needed to create two native, digital-government mobile applications. Itransition helped us through everything: requirements analysis, software design and engineering, automated building and testing, and tech writing. I personally recommended that Itransition be included in the 2017 Global Outsourcing list, and I am very happy to know they were selected,” commented Martin Duclos, Deputy Executive Director at NSPARC. “I strongly recommend Itransition to any business looking to outsource assistance for large-scale software development and testing,” he added. “We are honored to be included on the 2017 Global Outsourcing 100® list once again, delighted to surpass our previous results. Last year was a year of pushing the boundaries for the company, and those dynamics are reflected in higher scores from IAOP,” said Alex Demichev, Itransition’s CEO. “Achieving maximum scores in Customer References, Certification and Programs for Innovation areas is the result of our dedication to our clients, investment in constant specialist training and passion for innovation. Recognition from the globally acclaimed judges recharges our drive to deliver the best outsourcing services on the market.” About IAOP IAOP is the go-to association leading the way to improve outsourcing outcomes by bringing together customers, providers and advisors in a collaborative, knowledge-based environment that promotes professional development, recognition, certification and excellence. With over 120,000 members and affiliates worldwide, IAOP is not only on top of the latest trends but in front of them. Through its expansive global chapter network, premier training and certification programs, knowledge center, member community and more, IAOP helps members learn, grow and succeed. For more information and how you can become involved, visit www.IAOP.org About Itransition Founded in 1998, Itransition is a rapidly growing global provider of application and software product development services headquartered in the USA. The company delivers high quality services to customers from startups & SMBs to Fortune 500 companies through its 1,500 strong development center in Eastern Europe, offering a well-balanced blend of technology skills, domain knowledge, effective methodology, and passion for IT. Itransition is continuously recognized as a leader in outsourced software development by independent research agencies. For details, please visit: www.itransition.com Denver, CO, April 17, 2017 --( PR.com )-- Itransition , an outsourced software development vendor providing full-cycle IT services, is once again named one of the top service delivery providers in the global outsourcing industry by IAOP®, with special distinction and maximum scores in three areas: Customer References, Awards & Certifications, and Programs for Innovation.The 2017 Global Outsourcing 100 recognizes the world’s best outsourcing service providers. These list is based on applications received, and judging is based on a rigorous scoring methodology that includes reviews by an independent panel of IAOP customer members with extensive experience in selecting outsourcing service providers and advisors for their organizations.The 2017 panel is led by IAOP CEO Debi Hamill and Chairman Michael F. Corbett. The panel includes:· Daniel Beimborn, Professor, Frankfurt School of Finance & Management· Teresa Harris, COP, Global Supplier Relationship Manager, GE· Mary D. Lewis, Sourcing Manager II, Supply Chain Management, Sprint· Cheryl Seely, COP, Manager, Thomson Reuters· Paul Quaglia, COP, CIO, Scientific Games· Scott Singer, Managing Director, GBS, Rio TintoAs before, Size and Growth, Awards and Certifications, Programs for Innovation and Corporate Social Responsibility, as well as Customer References were the scored areas influencing the overall company score awarded by IAOP. To achieve “stars” in these categories, a company had to score 5 or more points (on a scale of 0-8).According to the 2017 GO100 results, Itransition not only scored above the industry average, but also beat its own overall score from 2016. Itransition stood out from competitors by being named Top Company in the areas of Customer References, Awards & Certifications, and Programs for Innovation, for which it received 8 points, the absolute maximum number. In the Programs for Innovation area, Itransition reached 8 as well beating its 2016 score by 3 points.The company also upped its 2016 score in the Company Awards area by 4 points. Having been included on the GO100 list for the last 9 consecutive years, Itransition received an additional distinction of Super Star of the Global Outsourcing 100 for demonstrating sustained excellence.“Buyers understand there are hundreds of qualified service providers and advisors out there, but what they really need to understand now is what makes each one exceptional,” said IAOP CEO, Debi Hamill. “The Global Outsourcing 100 and World’s Best Advisors lists have done just that. We are proud to recognize Itransition for being among the highest rated companies in Customer References, Company Awards, Company Certification, and Programs for Innovation.”“Since 2011, Itransition has enabled my organization to deliver quality products against tight deadlines. In late 2015, my organization needed to create two native, digital-government mobile applications. Itransition helped us through everything: requirements analysis, software design and engineering, automated building and testing, and tech writing. I personally recommended that Itransition be included in the 2017 Global Outsourcing list, and I am very happy to know they were selected,” commented Martin Duclos, Deputy Executive Director at NSPARC. “I strongly recommend Itransition to any business looking to outsource assistance for large-scale software development and testing,” he added.“We are honored to be included on the 2017 Global Outsourcing 100® list once again, delighted to surpass our previous results. Last year was a year of pushing the boundaries for the company, and those dynamics are reflected in higher scores from IAOP,” said Alex Demichev, Itransition’s CEO. “Achieving maximum scores in Customer References, Certification and Programs for Innovation areas is the result of our dedication to our clients, investment in constant specialist training and passion for innovation. Recognition from the globally acclaimed judges recharges our drive to deliver the best outsourcing services on the market.”About IAOPIAOP is the go-to association leading the way to improve outsourcing outcomes by bringing together customers, providers and advisors in a collaborative, knowledge-based environment that promotes professional development, recognition, certification and excellence. With over 120,000 members and affiliates worldwide, IAOP is not only on top of the latest trends but in front of them. Through its expansive global chapter network, premier training and certification programs, knowledge center, member community and more, IAOP helps members learn, grow and succeed. For more information and how you can become involved, visit www.IAOP.orgAbout ItransitionFounded in 1998, Itransition is a rapidly growing global provider of application and software product development services headquartered in the USA. The company delivers high quality services to customers from startups & SMBs to Fortune 500 companies through its 1,500 strong development center in Eastern Europe, offering a well-balanced blend of technology skills, domain knowledge, effective methodology, and passion for IT. Itransition is continuously recognized as a leader in outsourced software development by independent research agencies. For details, please visit: www.itransition.com Click here to view the company profile of Itransition Click here to view the list of recent Press Releases from Itransition


Grant
Agency: European Commission | Branch: FP7 | Program: CSA-SA | Phase: FP7-PEOPLE-2011-NIGHT | Award Amount: 124.70K | Year: 2011

Light11 is conceived as an event driving a cultural change about researchers for the benefit of research-end users. Light11 will take place in Rome, the capital of the country, and in 4 additional locations in the South of Italy thus covering large part of the country. Light11 makes scientists from all over Italy converge to Rome, Benevento, Cosenza, Palermo and Bari. Light11 will last from 5.p.m. on 23 September to 1.a.m on 24 September. Light is celebrating its 4th year of life. As in previous editions, we dedicate the RN to a specific theme. This year Light11 is dedicated to: Real science and TV fictions in order to show that real scientists may be as interesting and attracting as those proposed by TV fictions and that science is continuously shaping our daily existence in order to improve the understanding of the world around us and to stimulate curiosity for further developments. We will use the protagonists of science-related TV shows as a springboard for dialogue with the public in order to improve the image of scientists In order to ignite peoples curiosity towards scientists work, Light11 will set-up a number of actions/events during the whole RN. The actions will be run in continuation in all the locations allowing visitors to freely pass from one area to the other without waiting for something to happen. The activities will be organised around 5 main areas: o Hands-on workshops with live demonstrations and hands-on experiments; o Big ideas from young minds area, where potential tomorrows scientists will present their special achievements; o Globe Science Theatre where groups of artists/sportsmen that have at least one member of the performing team actively engaged with scientific research will be on stage during the whole RN; o Outside activities on sports and music o European Corner with Marie Curie research and training networks teams witnessing and answering public demands;

Loading GBS collaborators
Loading GBS collaborators